Leme Daniela Morais, Pestana Cynthia Bomfim, Kenny Elaine F, Feustel Sabrina, Marx-Stoelting Philip, Corsini Emanuela
Department of Genetics, Federal University of Paraná (UFPR), Curitiba, PR, Brazil.
German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Arch Toxicol. 2025 Aug 27. doi: 10.1007/s00204-025-04149-2.
Over the past years, the use of chemical pesticides has increased considerably worldwide, and concerns about human health and the environment have stimulated the development of safer alternatives. Biopesticides, including those with microorganisms as active substances, i.e. microbial pesticides, appear to be specific in action, easily sourced without the need for expensive chemicals, and environmentally sustainable with no residual effects. As such, they are seen as a viable alternative to synthetic pesticides. As with any other plant protection product, microbial pesticides are subjected to regulatory approval before marketing, and sensitisation, either via the dermal and/or inhalation routes, is one of the data requirements that have to be addressed in this process. The biological mechanisms underlying potential concerns related to sensitisation properties of microbial pesticides are reviewed in this article. Mechanistic knowledge was utilised to understand the potential limitations of current testing strategies for assessing sensitisation hazards, primarily defined by chemicals, as well as to demonstrate the potential value of New Approach Methodologies (NAMs) in this process. However, evaluating the sensitisation properties of microbial pesticides requires several protocol adaptations to achieve adequate confidence levels for alternative methods, narrow their applicability domain, and provide potency information on this endpoint. The technical limitations and difficulties in interpreting the results of current testing methods applied to microbial pesticides have long been recognised and are discussed in this article to better drive propositions of NAM-based strategies for microbial pesticides.
在过去几年中,化学农药的使用在全球范围内大幅增加,对人类健康和环境的担忧推动了更安全替代品的开发。生物农药,包括那些以微生物为活性物质的农药,即微生物农药,似乎作用具有特异性,易于获取,无需昂贵的化学品,并且对环境可持续,没有残留影响。因此,它们被视为合成农药的可行替代品。与任何其他植物保护产品一样,微生物农药在上市前需要经过监管批准,通过皮肤和/或吸入途径引起的致敏是这一过程中必须解决的数据要求之一。本文综述了与微生物农药致敏特性相关潜在问题的生物学机制。利用机制知识来理解当前评估致敏危害测试策略的潜在局限性,这些策略主要由化学品定义,同时也展示了新方法学(NAMs)在此过程中的潜在价值。然而,评估微生物农药的致敏特性需要对方案进行若干调整,以实现替代方法的足够置信水平,缩小其适用范围,并提供该终点的效力信息。应用于微生物农药的当前测试方法在解释结果方面的技术局限性和困难早已得到认可,本文对此进行了讨论,以便更好地推动基于NAMs的微生物农药策略的提议。